Vigilant Biosciences Launches Clinical Studies of Oral Cancer Assay
Vigilant Biosciences has launched patient enrollment for clinical studies of its OncAlert point-of-care qualitative assay in support of its registration submission to the.
Todays Dental News
Save Lives With Simple Oral Cancer Screenings
According to the World Health Organization, there are more than 529,000 new cases of oral (lip, oral cavity, and pharynx) cancer each year.
- October 17, 2016
- 5 minutes read
Industry News
Oral Cancer Test Gets European Conformity (CE) Mark
Vigilant Biosciences has received the European Conformity (CE) mark for its OncAlert Oral Cancer RAPID Test, enabling the company to market the product.
- May 6, 2016
- 1 minute read
